欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0288/001
药品名称EURICAN L3
活性成分
    • leptospira interrogans serogroup canicola 0.0 %
    • leptospira interrogans serogroup icterohaemorragiae 0.0 %
    • Leptospira kirschneri serogroup Grippotyphosa 0.0 %
剂型Suspension for injection
上市许可持有人MERIAL
参考成员国 - 产品名称France (FR)
EURICAN L3
互认成员国 - 产品名称
    • Germany (DE)
      Eurican L3
    • Denmark (DK)
      Eurican Lmulti
    • Belgium (BE)
      Eurican Lmulti
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
      Eurican L3
    • Ireland (IE)
    • Austria (AT)
      Eurican Lmulti, Injektionssuspension
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Latvia (LV)
      Eurican Lmulti
    • Lithuania (LT)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Poland (PL)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Malta (MT)
许可日期2015/07/22
最近更新日期2023/09/21
药物ATC编码
    • QI IMMUNOLOGICALS
    • QI07AB01 leptospira
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase